Reports acceleration of reimbursement claims submission for the CompuFlo® Epidural System TechnologyROSELAND, N.J., April 01, 2024 (GLOBE NEWSWIRE) Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the year ending December 31, 2023. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid financial